Concurrent Investment Advisors LLC Buys 13,000 Shares of Cigna Group $CI

Key Points

• Concurrent Investment Advisors LLC increased its stake in Cigna Group by 269.8% in Q4, buying 13,000 shares to hold 17,818 shares valued at approximately $4.904 million.
• Cigna beat Q4 expectations with $8.08 EPS vs. $7.88 est. and $72.5B revenue vs. $69.53B est., set FY‑2026 guidance at 30.25 EPS, and carries an average analyst rating of "Moderate Buy" with a $332.47 average price target.
• Multiple large institutions — including Capital Research, Massachusetts Financial Services, Ameriprise, M&T Bank and Man Group — materially boosted positions recently, leaving institutional investors with about 86.99% ownership of the stock.

Concurrent Investment Advisors LLC lifted its stake in Cigna Group (NYSE:CI - Free Report) by 269.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,818 shares of the health services provider's stock after purchasing an additional 13,000 shares during the quarter. Concurrent Investment Advisors LLC's holdings in Cigna Group were worth $4,904,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in CI. Capital Research Global Investors boosted its position in shares of Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider's stock worth $916,434,000 after purchasing an additional 1,855,897 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its position in shares of Cigna Group by 8.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider's stock worth $3,249,113,000 after purchasing an additional 903,334 shares in the last quarter. Ameriprise Financial Inc. boosted its position in shares of Cigna Group by 54.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider's stock worth $615,781,000 after purchasing an additional 753,865 shares in the last quarter. M&T Bank Corp boosted its position in shares of Cigna Group by 1,299.3% in the 4th quarter. M&T Bank Corp now owns 635,706 shares of the health services provider's stock worth $174,965,000 after purchasing an additional 590,277 shares in the last quarter. Finally, Man Group plc boosted its position in shares of Cigna Group by 215.5% in the 2nd quarter. Man Group plc now owns 532,183 shares of the health services provider's stock worth $175,929,000 after purchasing an additional 363,510 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

Analysts Set New Price Targets

CI has been the topic of a number of analyst reports. Leerink Partners boosted their price target on Cigna Group from $270.00 to $297.00 and gave the stock a "market perform" rating in a research report on Friday, February 6th. UBS Group reissued a "buy" rating and issued a $375.00 price target on shares of Cigna Group in a research report on Monday, February 9th. Weiss Ratings reissued a "hold (c-)" rating on shares of Cigna Group in a research report on Monday, December 29th. Mizuho set a $325.00 price target on Cigna Group in a research report on Friday, January 9th. Finally, TD Cowen boosted their price objective on shares of Cigna Group from $333.00 to $338.00 and gave the stock a "buy" rating in a report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group presently has an average rating of "Moderate Buy" and an average price target of $332.47.

Cigna Group Price Performance

Shares of NYSE CI opened at $275.44 on Monday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The firm has a market cap of $72.59 billion, a P/E ratio of 12.42, a PEG ratio of 0.95 and a beta of 0.26. The company has a 50 day moving average of $274.50 and a 200 day moving average of $277.02. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts' consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same period in the previous year, the business earned $6.64 EPS. The firm's revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, research analysts expect that Cigna Group will post 30.32 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Thursday, June 4th. Cigna Group's payout ratio is presently 28.13%.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna joined other major plans in a public commitment to standardize electronic prior-authorization requirements for commonly reviewed services — a move that should reduce provider administrative burden, speed patient access to care, and lower long‑term costs for payers. Article Title
• Positive Sentiment: Industry press highlights progress across UnitedHealthcare, Aetna and Cigna toward standardizing prior authorization — reinforcing that this is an industry-wide trend (reduces regulatory/operational risk if successfully implemented). Article Title
• Positive Sentiment: Cigna declared a quarterly dividend ($1.56 per share; ex-dividend in June), underscoring cash return to shareholders and supporting income-focused investor demand. Dividend Announcement
• Positive Sentiment: Analysts and previews (Zacks) expect earnings growth into the next report, which could support a post‑earnings rebound if Cigna posts another beat. Article Title
• Neutral Sentiment: Cigna promoted Melissa Skottegaard to chief marketing & communications officer — a leadership move that may affect branding/execution but is unlikely to move near‑term financials. Article Title
• Neutral Sentiment: Reminders that Cigna is scheduled to report results next week (earnings date/coverage notices) keep focus on near-term catalysts rather than fundamental surprises. Article Title
• Negative Sentiment: Jefferies reaffirmed a Buy on CI but trimmed its price target slightly (reportedly from $333 to $330) after reviewing health insurance exchange exposure — the analyst tweak likely pressured sentiment and fed selling pressure. Article Title

Insider Buying and Selling

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the business's stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the business's stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider owned 32,647 shares of the company's stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is owned by insiders.

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.